Routine PET Scans for Patients with Metastatic Non-Small Cell Lung Cancer: Clinical Effectiveness, Cost-effectiveness, and Guidelines (Last Updated: Mar 22, 2017)
Project Line:
Reference List
Current Filters
No filters applied.
MRI-Compatible Ventilators and Physiological Equipment for Adults Undergoing MRI exams: A Review of Clinical Effectiveness and Guidelines (Last Updated: Jun 20, 2020)
Project Line:
Health Technology Review
CADTH Pharmaceutical Reviews Update — Issue 25 () (Last Updated: Sep 16, 2021)
See Pharmaceutical Reviews Update ― Issue 25 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include: patient and clinician group input sponsor...
Project Line:
Reimbursement Review
selpercatinib (Retevmo) (Last Updated: Sep 14, 2021)
Project Line:
Reimbursement Review
Project Status:
Pending
Contains:
Brand Name
Manufacturer
Indications
Brand Name:
Retevmo
Manufacturer:
Eli Lilly Canada Inc.
Indications:
Retevmo is indicated as monotherapy for the treatment of: RET-mutant medullary thyroid cancer in adult and pediatric patients 12 years of age and older with unresectable advanced or metastatic disease, RET fusion-positive differentiated thyroid carcinoma in adult patients with advanced or metastatic disease (not amenable to surgery or radioactive iodine therapy) following prior treatment with sorafenib and/or lenvatinib.
cenegermin (Oxervate) (Last Updated: Sep 2, 2021)
Project Line:
Reimbursement Review
Project Status:
Pending
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Oxervate
Manufacturer:
Dompé Farmaceutici S.p.A
Submission Type:
Initial
Indications:
For the treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults.
Newer Biologics for the Treatment of Plaque Psoriasis (Last Updated: Sep 23, 2021)
Project Line:
Health Technology Review
Switching from Reference to Biosimilar Insulin Lispro for Patients with Diabetes Mellitus Type 1 or 2 (Last Updated: Feb 24, 2021)
Project Line:
Reference List
COVID-19 Update (Last Updated: Feb 22, 2021)
CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time. Our COVID-19 Evidence Portal contains the latest COVID-19 information from CADTH and...
Project Line:
New at CADTH
cariprazine (TBC) (Last Updated: Oct 1, 2021)
Project Line:
Reimbursement Review
Project Status:
Pending
Contains:
Brand Name
Manufacturer
Indications
Brand Name:
TBC
Manufacturer:
AbbVie Canada
Indications:
Cariprazine is anticipated to be indicated for the acute and long-term maintenance treatment of schizophrenia in adults.
Atomoxetine hydrochloride (Strattera) (Last Updated: Jan 25, 2005)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Strattera
Manufacturer:
Eli Lilly Canada Inc.
Submission Type:
Initial
Indications:
Attention deficit hyperactivity disorder